BIOGEN INC. Payments for (Proceeds from) Other Investing Activities
BIOGEN INC. (BIIB) reported Payments for (Proceeds from) Other Investing Activities of $200.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-04-29
- BIOGEN INC. payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $200.00K, a 0.00% change year-over-year.
- BIOGEN INC. payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was -$22.70M, a 7666.67% decline year-over-year.
- BIOGEN INC. payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was -$50.80M, a 4718.18% decline year-over-year.
- BIOGEN INC. payments for (proceeds from) other investing activities for the quarter ending 2025-06-30 was $30.40M, a 1069.23% increase year-over-year.
- BIOGEN INC. payments for (proceeds from) other investing activities for fiscal 2025 was -$42.90M, a 1012.77% decline from fiscal 2024.
- BIOGEN INC. payments for (proceeds from) other investing activities for fiscal 2024 was $4.70M, a 58.41% decline from fiscal 2023.
- BIOGEN INC. payments for (proceeds from) other investing activities for fiscal 2023 was $11.30M.
- BIOGEN INC. payments for (proceeds from) other investing activities for fiscal 2022 was -$24.40M.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 3 month as first filed | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 6 month as first filed | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 9 month as first filed | Payments for (Proceeds from) Other Investing Activities 12 month | Payments for (Proceeds from) Other Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $200.00K 10-Q · filed 2026-04-29 | -$22.50M derived: sum of 2 quarters · filed 2026-04-29 | -$73.30M derived: sum of 3 quarters · filed 2026-04-29 | -$42.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$22.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$73.50M derived: sum of 2 quarters · filed 2026-02-06 | -$43.10M derived: sum of 3 quarters · filed 2026-02-06 | -$42.90M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | -$50.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$20.40M derived: sum of 2 quarters · filed 2025-10-30 | -$20.20M 10-Q · filed 2025-10-30 | -$19.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $30.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $30.60M 10-Q · filed 2025-07-31 | $30.90M derived: sum of 3 quarters · filed 2026-04-29 | $32.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $200.00K 10-Q · filed 2026-04-29 | $500.00K derived: sum of 2 quarters · filed 2026-04-29 | $1.60M derived: sum of 3 quarters · filed 2026-04-29 | $4.20M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.40M derived: sum of 2 quarters · filed 2026-02-06 | $4.00M derived: sum of 3 quarters · filed 2026-02-06 | $4.70M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.70M derived: sum of 2 quarters · filed 2025-10-30 | $4.40M 10-Q · filed 2025-10-30 | $14.40M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $3.30M 10-Q · filed 2025-07-31 | $13.30M derived: sum of 3 quarters · filed 2026-02-06 | $13.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $700.00K 10-Q · filed 2025-05-01 | $10.70M derived: sum of 2 quarters · filed 2026-02-06 | $10.90M derived: sum of 3 quarters · filed 2026-02-06 | $11.30M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $10.20M derived: sum of 2 quarters · filed 2026-02-06 | $10.60M derived: sum of 3 quarters · filed 2026-02-06 | $11.30M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $600.00K derived: sum of 2 quarters · filed 2024-10-30 | $1.30M 10-Q · filed 2024-10-30 | -$21.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.10M 10-Q · filed 2024-08-01 | -$21.50M derived: sum of 3 quarters · filed 2025-02-12 | -$21.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $700.00K 10-Q · filed 2024-04-24 | -$21.90M derived: sum of 2 quarters · filed 2025-02-12 | -$21.70M derived: sum of 3 quarters · filed 2025-02-12 | -$23.90M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$22.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$22.40M derived: sum of 2 quarters · filed 2025-02-12 | -$24.60M derived: sum of 3 quarters · filed 2025-02-12 | -$24.40M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.00M derived: sum of 2 quarters · filed 2023-11-08 | -$1.80M 10-Q · filed 2023-11-08 | -$14.10M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$2.00M 10-Q · filed 2023-07-25 | -$14.30M derived: sum of 3 quarters · filed 2024-02-14 | -$12.90M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $200.00K 10-Q · filed 2023-04-25 | -$12.10M derived: sum of 2 quarters · filed 2024-02-14 | -$10.70M derived: sum of 3 quarters · filed 2024-02-14 | -$10.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$10.90M derived: sum of 2 quarters · filed 2024-02-14 | -$10.20M derived: sum of 3 quarters · filed 2024-02-14 | -$12.90M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $2.10M derived: sum of 2 quarters · filed 2022-10-25 | -$600.00K 10-Q · filed 2022-10-25 | $8.30M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$2.00M 10-Q · filed 2022-07-20 | $6.90M derived: sum of 3 quarters · filed 2023-02-15 | $17.10M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$2.70M 10-Q · filed 2022-05-03 | $6.20M derived: sum of 2 quarters · filed 2023-02-15 | $16.40M derived: sum of 3 quarters · filed 2023-02-15 | $23.70M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $19.10M derived: sum of 2 quarters · filed 2023-02-15 | $26.40M derived: sum of 3 quarters · filed 2023-02-15 | $26.90M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $17.50M derived: sum of 2 quarters · filed 2021-10-20 | $18.00M 10-Q · filed 2021-10-20 | -$13.60M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $7.80M 10-Q · filed 2021-07-22 | $0.00 10-Q · filed 2020-07-22 | -$23.80M derived: sum of 3 quarters · filed 2022-02-03 | -$23.20M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-03-31 | $500.00K 10-Q · filed 2021-04-22 | -$31.10M derived: sum of 2 quarters · filed 2022-02-03 | -$30.50M derived: sum of 3 quarters · filed 2022-02-03 | -$24.80M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | -$31.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$31.00M derived: sum of 2 quarters · filed 2022-02-03 | -$25.30M derived: sum of 3 quarters · filed 2022-02-03 | -$27.00M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $6.30M derived: sum of 2 quarters · filed 2020-10-21 | $4.60M 10-Q · filed 2020-10-21 | $5.40M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $4.00M 10-Q · filed 2020-07-22 | $4.80M derived: sum of 3 quarters · filed 2021-02-03 | $5.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$1.70M 10-Q · filed 2020-04-23 | -$900.00K derived: sum of 2 quarters · filed 2021-02-03 | $0.00 derived: sum of 3 quarters · filed 2021-02-03 | -$500.00K derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $1.70M derived: sum of 2 quarters · filed 2021-02-03 | $1.20M derived: sum of 3 quarters · filed 2021-02-03 | -$400.00K 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $400.00K derived: sum of 2 quarters · filed 2019-10-22 | -$1.20M 10-Q · filed 2019-10-22 | $4.70M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$2.10M 10-Q · filed 2019-07-24 | -$2.90M 10-Q · filed 2018-07-24 | $3.80M derived: sum of 3 quarters · filed 2020-02-06 | $1.70M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-03-31 | -$1.60M 10-Q · filed 2019-04-24 | $4.30M derived: sum of 2 quarters · filed 2020-02-06 | $2.20M derived: sum of 3 quarters · filed 2020-02-06 | $2.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $3.80M derived: sum of 2 quarters · filed 2020-02-06 | $4.40M derived: sum of 3 quarters · filed 2020-02-06 | $11.00M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$1.50M derived: sum of 2 quarters · filed 2018-10-23 | $5.10M 10-Q · filed 2018-10-23 | $15.10M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $7.20M 10-Q · filed 2018-07-24 | $7.30M 10-Q · filed 2017-07-25 | $17.20M derived: sum of 3 quarters · filed 2019-02-06 | -$35.90M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-03-31 | $6.60M 10-Q · filed 2018-04-24 | $16.60M derived: sum of 2 quarters · filed 2019-02-06 | -$36.50M derived: sum of 3 quarters · filed 2019-02-06 | $15.00M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$43.10M derived: sum of 2 quarters · filed 2019-02-06 | $8.40M derived: sum of 3 quarters · filed 2019-02-06 | $22.80M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | -$53.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$1.60M derived: sum of 2 quarters · filed 2017-10-24 | $12.80M 10-Q · filed 2017-10-24 | $29.90M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $51.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $65.90M 10-Q · filed 2017-07-25 | $83.00M derived: sum of 3 quarters · filed 2018-02-01 | $100.30M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $14.40M 10-Q · filed 2017-04-25 | $43.00M 10-Q · filed 2016-04-21 | $31.50M derived: sum of 2 quarters · filed 2018-02-01 | $48.80M derived: sum of 3 quarters · filed 2018-02-01 | $52.20M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2015-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $34.40M derived: sum of 2 quarters · filed 2018-02-01 | $37.80M derived: sum of 3 quarters · filed 2018-02-01 | $44.50M 10-K · filed 2018-02-01 | $59.90M 10-K · filed 2016-02-03 | |||
| 2015-09-30 | $17.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $20.70M derived: sum of 2 quarters · filed 2016-10-26 | $27.40M 10-Q · filed 2016-10-26 | $33.62M 10-Q · filed 2015-10-21 | $2.07M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $10.10M 10-Q · filed 2016-07-21 | $10.12M 10-Q · filed 2015-07-24 | -$15.23M derived: sum of 3 quarters · filed 2017-02-02 | -$12.85M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $6.70M 10-Q · filed 2016-04-21 | $6.75M 10-Q · filed 2015-04-24 | -$18.63M derived: sum of 2 quarters · filed 2017-02-02 | -$16.25M derived: sum of 3 quarters · filed 2017-02-02 | -$11.50M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$25.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$22.95M derived: sum of 2 quarters · filed 2017-02-02 | -$18.20M derived: sum of 3 quarters · filed 2017-02-02 | -$12.20M 10-K · filed 2017-02-02 | $16.00M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $7.13M derived: sum of 2 quarters · filed 2015-10-21 | $13.13M 10-Q · filed 2015-10-21 | -$10.12M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $10.74M 10-Q · filed 2015-07-24 | -$12.51M derived: sum of 3 quarters · filed 2016-02-03 | -$3.43M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $6.00M 10-Q · filed 2015-04-24 | -$17.25M derived: sum of 2 quarters · filed 2016-02-03 | -$8.17M derived: sum of 3 quarters · filed 2016-02-03 | -$12.89M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$23.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$14.17M derived: sum of 2 quarters · filed 2016-02-03 | -$18.90M derived: sum of 3 quarters · filed 2016-02-03 | -$7.30M 10-K · filed 2016-02-03 | -$7.37M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $9.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $4.36M derived: sum of 2 quarters · filed 2014-10-22 | $15.95M 10-Q · filed 2014-10-22 | $16.46M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | -$4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $6.87M 10-Q · filed 2014-07-23 | $7.38M derived: sum of 3 quarters · filed 2015-02-04 | $22.74M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $11.60M 10-Q · filed 2014-04-23 | $12.10M derived: sum of 2 quarters · filed 2015-02-04 | $27.47M derived: sum of 3 quarters · filed 2015-02-04 | $30.34M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $15.87M derived: sum of 2 quarters · filed 2015-02-04 | $18.75M derived: sum of 3 quarters · filed 2015-02-04 | $38.52M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $15.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $18.24M derived: sum of 2 quarters · filed 2013-10-28 | $38.01M 10-Q · filed 2013-10-28 | $46.75M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $22.65M 10-Q · filed 2013-07-25 | $31.38M derived: sum of 3 quarters · filed 2014-02-06 | $61.02M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $19.77M 10-Q · filed 2013-04-25 | $28.51M derived: sum of 2 quarters · filed 2014-02-06 | $58.15M derived: sum of 3 quarters · filed 2014-02-06 | $62.77M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $38.38M derived: sum of 2 quarters · filed 2014-02-06 | $42.99M derived: sum of 3 quarters · filed 2014-02-06 | $17.00M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $29.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $34.26M derived: sum of 2 quarters · filed 2012-10-25 | $8.27M 10-Q · filed 2012-10-25 | |||||
| 2011-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | -$21.38M 10-Q · filed 2012-07-24 | ||||||
| 2011-03-31 | -$26.00M 10-Q · filed 2012-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |